Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 9/20 | 0.66 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.56 |
| ▸ | MAOA | P21397 | 2/20 | 0.54 |
| ▸ | IDO1 | P14902 | 2/20 | 0.51 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.51 |
| ▸ | ACHE | P22303 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30398600 | 1.00 | MAOB (0.66) | MAOBFFAR1MAOAIDO1NR1H4 | |
| SCHEMBL962614 | 0.87 | MAOB (0.62) | MAOBFFAR1MAOA | |
| SCHEMBL29496958 | 0.87 | MAOB (0.62) | MAOBFFAR1MAOA | |
| SCHEMBL10866245 | 0.86 | MAOB (0.69) | MAOBFFAR1MAOAIDO1NR1H4 | |
| SCHEMBL257781 | 0.86 | MAOB (0.69) | MAOBFFAR1MAOAIDO1ACHE | |
| SCHEMBL23004604 | 0.83 | MAOB (0.62) | MAOBFFAR1MAOAIDO1NR1H4 | |
| SCHEMBL28498324 | 0.83 | MAOB (0.61) | MAOBFFAR1MAOAIDO1NR1H4 | |
| SCHEMBL20724026 | 0.83 | MAOB (0.64) | MAOBFFAR1MAOAIDO1NR1H4 | |
| SCHEMBL30399092 | 0.83 | MAOB (0.62) | MAOBFFAR1MAOAIDO1NR1H4 | |
| SCHEMBL21480345 | 0.83 | MAOB (0.78) | MAOBMAOAIDO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112010818-B | Morpholinamide derivatives and uses thereof | 广东东阳光药业股份有限公司 | 2024-01-16 | — | — | CN | disclosed |
| EP-3762364-B1 | PYRROLIDINEAMIDE DERIVATIVES AND USES THEREOF | SUNSHINE LAKE PHARMA CO LTD (CN) | 2023-08-23 | — | — | EP | disclosed |
| CN-110240557-B | Pyrrolidine amide derivatives and use thereof | 广东东阳光药业有限公司 | 2023-05-09 | — | — | CN | disclosed |
| US-11225460-B2 | Pyrrolidineamide derivatives and uses thereof | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2022-01-18 | — | — | US | disclosed |
| US-20210053918-A1 | PYRROLIDINEAMIDE DERIVATIVES AND USES THEREOF | SUNSHINE LAKE PHARMA CO., LTD. (CN) | 2021-02-25 | — | — | US | disclosed |
| CN-112010818-A | Morpholine amide derivative and application thereof | 广东东阳光药业有限公司 | 2020-12-01 | — | — | CN | disclosed |
| CN-110240557-A | Pyrrolidine derivative and application thereof | 广东东阳光药业有限公司 | 2019-09-17 | — | — | CN | disclosed |
| US-7253318-B2 | Benzyloxy derivatives as MAOB inhibitors | HOFFMAN-LA ROCHE INC. (US) | 2007-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11225460-B2 | Pyrrolidineamide derivatives and uses thereof | MAOB, MAOA, PARK7 | MAOB 1/4885FFAR1 3993/4885MAOA 2/4885 |
| US-20210053918-A1 | PYRROLIDINEAMIDE DERIVATIVES AND USES THEREOF | MAOB, MAOA, PARK7 | MAOB 1/4885FFAR1 3993/4885MAOA 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.